FUNCTIONS OF ATP-BINDING CASSETTE (ABC) TRANSPORTERS

被引:0
作者
Bamburowicz-Klimkowska, Magdalena [1 ]
Bogucka, Urszula [1 ]
Szutowski, Miroslaw M. [1 ]
机构
[1] Warszawski Uniwersytet Medyczny, Katedra Zaklad Toksykol Wydzial Farmaceutyczn, Ul Banacha 1, PL-02097 Warsaw, Poland
来源
BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO | 2011年 / 03期
关键词
ATP-binding cassette [ABC] transporters; P-glycoprotein;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several types of transporters present in the body control the fate of drugs by affecting uptake, distribution, and elimination processes. Among other functions, these proteins mediate the influx and efflux of endogenous as well as exogenous substances across the membranes of the small intestine, bile duct, and blood-brain barrier. In polypharmacotherapy, ATP-dependent transporters (ATP-binding cassette [ABC] transporters) expressed on the apical membrane of intestinal epithelial cells determine oral bioavailability, intestinal efflux clearance, and drug-drug interactions of certain xenobiotics. P-glycoprotein (Pgp), product of the human MDR1 gene, is one of the most important proteins belonging to the ABC transporter superfamily. The tissue and organ distribution of Pgp significantly affects the uptake of xenobiotics, and interactions of drugs with this protein may alter bioavailability of other drugs that are administered simultaneously. The subfamilies of ATP-dependent efflux transporters are discussed, with emphasis on their functions.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 39 条
  • [1] The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours
    Bart, J
    Hollema, H
    Groen, HJM
    de Vries, EGE
    Hendrikse, NH
    Sleijfer, DT
    Wegman, TD
    Vaalburg, W
    van der Graaf, WTA
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (14) : 2064 - 2070
  • [2] Molecular models of human P-glycoprotein in two different catalytic states
    Becker, Jean-Paul
    Depret, Gregoire
    Van Bambeke, Francoise
    Tulkens, Paul M.
    Prevost, Martine
    [J]. BMC STRUCTURAL BIOLOGY, 2009, 9
  • [3] The drug efflux-metabolism alliance: biochemical aspects
    Benet, LZ
    Cummins, CL
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 : S3 - S11
  • [4] Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology:: Structural model of the nucleotide binding domains of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
    Bianchet, MA
    Ko, YH
    Amzel, LM
    Pedersen, PL
    [J]. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1997, 29 (05) : 503 - 524
  • [5] A family of drug transporters: The multidrug resistance-associated proteins
    Borst, P
    Evers, R
    Kool, M
    Wijnholds, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16): : 1295 - 1302
  • [6] Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs
    Breedveld, P
    Beijnen, JH
    Schellens, JHM
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (01) : 17 - 24
  • [7] Czajka-Uhryn M., 2005, ANN ACAD MED SILESIE, V59, P209
  • [8] The human ATP-binding cassette (ABC) transporter superfamily
    Dean, M
    Rzhetsky, A
    Allikmets, R
    [J]. GENOME RESEARCH, 2001, 11 (07) : 1156 - 1166
  • [9] Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
    Doyle, LA
    Ross, DD
    [J]. ONCOGENE, 2003, 22 (47) : 7340 - 7358
  • [10] P-glycoprotein - A mediator of multidrug resistance in tumour cells
    Germann, UA
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) : 927 - 944